Schedule 13D ownership disclosure

LIPELLA PHARMACEUTICALS INC.

Common Stock, par value $0.0001 per share · CUSIP: 53630L209

Event date: 2025-01-15

Filing-level shares
212,289.00
Percent of class
16.2%
  • Jonathan H. KaufmanReported CIK 0001959250

    Shares: 212,289.00 · Class: 16.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001753926-25-000103
Form type
SCHEDULE 13D/A
Filer
Kaufman Jonathan H
CIK
CIK 1959250
Filed
Jan 17, 2025
Reporting period
Jan 15, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub